HighTower Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.1M | Buy |
34,603
+138
| +0.4% | +$45.4K | 0.01% | 880 |
|
|
2025
Q4 | $12.1M | Sell |
34,465
-799
| -2% | -$270K | 0.01% | 788 |
|
|
2025
Q3 | $11.4M | Sell |
35,264
-2,746
| -7% | -$854K | 0.01% | 800 |
|
|
2025
Q2 | $14.8M | Sell |
38,010
-1,922
| -5% | -$773K | 0.02% | 654 |
|
|
2025
Q1 | $17.4M | Sell |
39,932
-1,425
| -3% | -$572K | 0.02% | 576 |
|
|
2024
Q4 | $15.3M | Sell |
41,357
-27,656
| -40% | -$11.6M | 0.02% | 600 |
|
|
2024
Q3 | $35.9M | Sell |
69,013
-21,739
| -24% | -$11.6M | 0.05% | 354 |
|
|
2024
Q2 | $49.2M | Buy |
90,752
+78
| +0.1% | +$41.2K | 0.08% | 261 |
|
|
2024
Q1 | $47.1M | Buy |
90,674
+1,952
| +2% | +$971K | 0.08% | 266 |
|
|
2023
Q4 | $41.7M | Buy |
88,722
+6,070
| +7% | +$2.81M | 0.07% | 279 |
|
|
2023
Q3 | $35.9M | Buy |
82,652
+892
| +1% | +$405K | 0.07% | 284 |
|
|
2023
Q2 | $36.2M | Sell |
81,760
-4,707
| -5% | -$2.17M | 0.07% | 273 |
|
|
2023
Q1 | $39.8M | Buy |
86,467
+1,970
| +2% | +$938K | 0.09% | 247 |
|
|
2022
Q4 | $43.4M | Buy |
84,497
+611
| +0.7% | +$310K | 0.1% | 222 |
|
|
2022
Q3 | $38.2M | Buy |
83,886
+7,021
| +9% | +$3.36M | 0.1% | 215 |
|
|
2022
Q2 | $37.1M | Sell |
76,865
-1,918
| -2% | -$949K | 0.1% | 221 |
|
|
2022
Q1 | $38.7M | Buy |
78,783
+1,010
| +1% | +$462K | 0.09% | 240 |
|
|
2021
Q4 | $36.1M | Buy |
77,773
+18,957
| +32% | +$7.98M | 0.08% | 253 |
|
|
2021
Q3 | $21.9M | Buy |
58,816
+1,045
| +2% | +$397K | 0.06% | 320 |
|
|
2021
Q2 | $22.1M | Buy |
57,771
+724
| +1% | +$277K | 0.06% | 289 |
|
|
2021
Q1 | $20.5M | Buy |
57,047
+3,543
| +7% | +$1.14M | 0.06% | 301 |
|
|
2020
Q4 | $17.1M | Buy |
53,504
+24,905
| +87% | +$7.64M | 0.07% | 263 |
|
|
2020
Q3 | $7.68M | Buy |
28,599
+8,222
| +40% | +$2.21M | 0.04% | 415 |
|
|
2020
Q2 | $5.39M | Buy |
20,377
+7,662
| +60% | +$2.04M | 0.03% | 492 |
|
|
2020
Q1 | $2.88M | Buy |
+12,715
| New | +$3.47M | 0.02% | 623 |
|
|
2019
Q4 | – | Sell |
-11,239
| Closed | -$2.7M | – | 2422 |
|
|
2019
Q3 | $2.7M | Sell |
11,239
-10,847
| -49% | -$2.97M | 0.01% | 786 |
|
|
2019
Q2 | $6.27M | Buy |
22,086
+8,686
| +65% | +$2.37M | 0.04% | 482 |
|
|
2019
Q1 | $3.85M | Sell |
13,400
-2,366
| -15% | -$684K | 0.03% | 609 |
|
|
2018
Q4 | $4.15M | Sell |
15,766
-7,059
| -31% | -$1.94M | 0.03% | 515 |
|
|
2018
Q3 | $6.24M | Buy |
22,825
+164
| +0.7% | +$42.6K | 0.05% | 440 |
|
|
2018
Q2 | $5.41M | Sell |
22,661
-2,313
| -9% | -$536K | 0.04% | 469 |
|
|
2018
Q1 | $5.49M | Buy |
24,974
+1,300
| +5% | +$305K | 0.05% | 441 |
|
|
2017
Q4 | $5.33M | Buy |
23,674
+1,929
| +9% | +$411K | 0.04% | 442 |
|
|
2017
Q3 | $4.13M | Sell |
21,745
-144
| -0.7% | -$27.4K | 0.04% | 535 |
|
|
2017
Q2 | $4.13M | Buy |
21,889
+1,029
| +5% | +$185K | 0.04% | 527 |
|
|
2017
Q1 | $3.44M | Buy |
20,860
+3,776
| +22% | +$601K | 0.03% | 566 |
|
|
2016
Q4 | $2.45M | Sell |
17,084
-2,143
| -11% | -$287K | 0.03% | 633 |
|
|
2016
Q3 | $2.41M | Sell |
19,227
-62,535
| -76% | -$8.07M | 0.03% | 598 |
|
|
2016
Q2 | $10.7M | Buy |
81,762
+185
| +0.2% | +$25.3K | 0.14% | 151 |
|
|
2016
Q1 | $11.4M | Buy |
81,577
+9,352
| +13% | +$1.25M | 0.04% | 175 |
|
|
2015
Q4 | $10.1M | Sell |
72,225
-283
| -0.4% | -$39K | 0.12% | 184 |
|
|
2015
Q3 | $10.2M | Buy |
+72,508
| New | +$10.9M | 0.13% | 166 |
|
|
2015
Q2 | – | Sell |
-67,800
| Closed | -$10.5M | – | 1640 |
|
|
2015
Q1 | $10.5M | Sell |
67,800
-1,572
| -2% | -$224K | 0.16% | 146 |
|
|
2014
Q4 | $8.72M | Buy |
69,372
+16,635
| +32% | +$2.06M | 0.13% | 178 |
|
|
2014
Q3 | $6.31M | Buy |
52,737
+1,967
| +4% | +$226K | 0.11% | 227 |
|
|
2014
Q2 | $5.46M | Buy |
50,770
+48,662
| +2,308% | +$5.01M | 0.09% | 233 |
|
|
2014
Q1 | $210K | Sell |
2,108
-5,099
| -71% | -$461K | ﹤0.01% | 1297 |
|
|
2013
Q4 | $666K | Buy |
7,207
+468
| +7% | +$41.6K | 0.01% | 852 |
|
|
2013
Q3 | $563K | Buy |
+6,739
| New | +$578K | 0.01% | 802 |
|
Other funds holding ELV
VCM
VPM
HighTower Advisors's ELV Position: Q1 2026 in Review
HighTower Advisors increased its Elevance Health (ELV) stake by 0.4% in Q1 2026, buying an estimated $45.4K and bringing the position to 34,603 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #880.
HighTower Advisors first reported a position in ELV in Q3 2013 and has held it in 49 quarters since. The position peaked at $49.2M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- HighTower Advisors held 34,603 shares of Elevance Health worth $10.1M as of Q1 2026.
- HighTower Advisors bought 138 Elevance Health shares in Q1 2026, an estimated $45.4K.
- Elevance Health made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #880 holding.
- HighTower Advisors first reported a position in Elevance Health in Q3 2013 and has held it in 49 quarters since.
- HighTower Advisors's Elevance Health position peaked at $49.2M in Q2 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.